LOW-VOLUME · SEX-BALANCED

protriptyline Side Effects

protriptyline (also sold as Vivactil) is a LOW-VOLUME FAERS extract #519 of 524 by FAERS report count. Still opens on SEX-BALANCED: 68% of sex-coded reports are female (61 F / 29 M).

Data updated 2026-05-15

96
FAERS reports

Thinner FAERS book - still a temporal association ledger, not proof of cause. Methodology.

protriptyline reporting skew - 68% of sex-coded reports are female (61 F / 29 M). Volume band LOW-VOLUME #519 of 524 by FAERS report count; caseload TRACE-CASE.

Thinner FAERS extract for protriptyline (Vivactil) (96 reports #519 of 524 by FAERS report count). 68% of sex-coded reports are female (61 F / 29 M). Sparse books still carry named reaction rows when present; not medical advice.

Counts from the openFDA FAERS extract (2012–2025). Stamps TRACE-CASE · DEATH-RARE · HOSP-MID · SEX-BALANCED.

FALL leads 12 of 96 reports

FALL
12
PRODUCT ADMINISTRATION INTERRUPTED
8
SLEEP APNOEA SYNDROME
8
ANXIETY
7
DEPRESSION
6
DIZZINESS
6
BLOOD PRESSURE INCREASED
5
COVID-19
5
HYPERTENSION
5
ILLNESS
5
WEIGHT INCREASED
5
ABDOMINAL DISCOMFORT
4
DYSPNOEA
4
FATIGUE
4
GAIT DISTURBANCE
4
HEADACHE
4
HOSPITALISATION
4
LOSS OF CONSCIOUSNESS
4

Who reports · age peak 18-44 (SEX-BALANCED)

Sex coding · SEX-BALANCED

Female 61 (68%)
Male 29 (32%)

Age peak 18-44 (14 reports)

0-17 1 (2%)
18-44 14 (31%)
45-64 12 (27%)
65-74 12 (27%)
75+ 6 (13%)

FAERS filings rising toward 2025

12
13
15
16
17
18
19
20
21
22
23
24
25

Reactions in Hospitalization Reports

Hospitalization mid-share (24, 25.0%). Co-reported reactions:

Reaction Reports
FALL 5
HOSPITALISATION 4
ILLNESS 3
PRODUCT ADMINISTRATION INTERRUPTED 3
ABDOMINAL DISCOMFORT 2
ANXIETY 2
CONDITION AGGRAVATED 2
DIZZINESS 2
DYSPNOEA 2
HEAD INJURY 2
HYPERTENSION 2
HYPOGLYCAEMIA 2
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2
LOSS OF CONSCIOUSNESS 2
MUSCLE SPASMS 2
OSTEOARTHRITIS 2
PAIN 2
SEIZURE 2
VOMITING 2
WITHDRAWAL SYNDROME 2
How to read protriptyline FAERS figures (TRACE-CASE · DEATH-RARE · HOSP-MID)

FAERS holds 96 voluntary reports linked to protriptyline (Vivactil), 2012-2025. No death outcome in this extract. Hospitalization appears on 24 (25.0%). Top co-reported indication: Product Used For Unknown Indication.

Sparse extract - named reactions and SEX-BALANCED skew still differ by drug; not a complete safety profile.

Read with protriptyline

Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-RARE · HOSP-MID stamps.